As the title implies, this final rule clarifies and amends the discount safe harbor at 42 C.F.R. § 1001.925(h) under the federal Anti-kickback statute (AKS) such that rebates paid from drug manufacturers to Medicare Part D prescription drug plan sponsors or their pharmacy benefit managers (PBMs) are not protected from liability under the discount safe harbor. The rule also adds a new safe harbor for point-of-sale reductions in price that are passed on directly to a buyer (a defined term under the rule) and an additional safe harbor for “legitimate” service fees paid to PBMs by drug manufacturers.
OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees
More Issues
Wade’s Health Law Highlights for August 18, 2026
A Houston-area pharmacist was convicted of conspiracy to pay health care kickbacks after paying more than $2 million for patient referrals Tronown Thomas owned…
Wade’s Health Law Highlights for August 11, 2026
False Claims Act settlements and judgments announced in the first half of 2026 total more than $1.8 billion The total includes two nine-figure Medicare…
Wade’s Health Law Highlights for July 28, 2026
A Dallas clinical laboratory, its owners, and its investors agreed to pay $24 million to resolve False Claims Act allegations that it billed Medicare…
